By combining CJC-1295 No DAC (GHRH pathway activation) with Ipamorelin (ghrelin receptor pathway activation), the strategy mimics this multi-pathway regulation, potentially recreating more physiological GH secretion patterns than achievable with single-pathway stimulation
With the approval, Rybelsus becomes the first oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the EU with proven cardiovascular benefits
The way it was executed was maybe not satisfying to people, and it was in no way tied up in a bow
Honestly, I notice Im snacking less and actually feel satisfied with smaller meals
Yes, it improves insulin sensitivity, which may help with insulin resistance
They also prioritize GLP-1 RAs for patients in whom weight loss is desired or hypoglycemia avoidance is a concern